Metabolic engineering of resveratrol and other longevity boosting compounds

BioFactors

Volumn 36, Issue 5, 2010, Pages 394-400

  Wang, Yechun ^a   Chen, Hui ^a   Yu, Oliver ^a  

^a DONALD DANFORTH PLANT SCIENCE CENTER   (United States)

Author keywords

Longevity; Metabolic engineering; Resveratrol

Indexed keywords

ACETYLSALICYLIC ACID; METFORMIN; NORDIHYDROGUAIARETIC ACID; PICEID; RAPAMYCIN; RESVERATROL; SRT 1720; UNCLASSIFIED DRUG;

ARTICLE; BIOSYNTHESIS; DRUG MECHANISM; DRUG METABOLISM; LONGEVITY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ASPIRIN; GENETIC ENGINEERING; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; LONGEVITY; METFORMIN; NORDIHYDROGUAIARETIC ACID; SACCHAROMYCES CEREVISIAE; SIROLIMUS; STILBENES;

EUKARYOTA; VITACEAE;

EID: 78651514625     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.126     Document Type: Article

References (72)

1. Takaoka, M. J. (1940) Of the phenolic substances of white hellebore (Veratrum grandiflorum Loes. Fil.). J. Fac. Sci. Hokkaido Imp. Univ. 3, 1-16.
2. Nonomura, S., Kanagawa, H., and Makimoto, A. (1963) Chemical constituents of polygonaceous plants. I. Studies on the components of Ko-jo-kon. Yakugaku Zasshi 83, 988-990.
3. Becker, J. V., Armstrong, G. O., van der Merwe, M. J., Lambrechts, M. G., Vivier, M. A., and Pretorius, I. S. (2003) Metabolic engineering of Saccharomyces cerevisiae for the synthesis of the wine-related antioxidant resveratrol. FEMS Yeast Res. 4, 79-85.
4. Langcake, P. and Pryce, R. J. (1976) The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection and injury. Physiol. Plant Pathol. 9, 77-86.
5. Hart, J. H. (1981) Role of phytostilbenes in decay and disease resistance. Ann. Rev. Phytopathol. 19, 437-458.
6. Soleas, G. J., Diamandis, E. P., and Goldberg, D. M. (1997) Wine as a biological fluid: history, production, and role in disease prevention. J. Clin. Lab. Anal. 11, 287-313.
7. Gu, X., Creasy, L., Kester, A., and Zeece, M. (1999) Capillary electrophoretic determination of resveratrol in wines. J. Agric. Food Chem. 47, 3223-3227.
8. Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W., Fong, H. H., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., Moon, R. C., and Pezzuto, J. M. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275, 218-220.
9. Campagna, M. and Rivas, C. (2010) Antiviral activity of resveratrol. Biochem. Soc. Trans. 38, 50-53.
10. Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L. L., Scherer, B., and Sinclair, D. A. (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425, 191-196.
11. Wood, J. G., Rogina, B., Lavu, S., Howitz, K., Helfand, S. L., Tatar, M., and Sinclair, D. (2004) Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430, 686-689.
12. Barger, J. L., Kayo, T., Vann, J. M., Arias, E. B., Wang, J., Hacker, T. A., Wang, Y., Raederstorff, D., Morrow, J. D., Leeuwenburgh, C., Allison, D. B., Saupe, K. W., Cartee, G. D., Weindruch, R., and Prolla, T. A. (2008) A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PLoS One 3, e2264.
13. Barer, J. H., Goupil, S., Garber, G. B., and Helfand, S. L. (2004) An accelerated assay for the identification of life span-extending interventions in Drosophila melanogaster. Proc. Natl. Acad. Sci. USA 35, 12980-12985.
14. Valenzano, D. R., Terzibasi, E., Genade, T., Cattaneo, A., Domenici, L., and Cellerino, A. (2006) Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Curr. Biol. 16, 296-300.
15. Baur, J. A. (2010) Resveratrol, sirtuins, and the promise of a DR mimetic. Mech. Ageing Dev. 131, 261-269.
16. Kaeberlein, M., McVey, M., and Guarente, L. (1999) The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev. 13, 2570-2580.
17. Tissenbaum, H. A. and Guarente, L. (2001) Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 410, 227-230.
18. Rogina, B. and Helfand, S. L. (2004) Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc. Natl. Acad. Sci. USA 101, 15998-16003.
19. Um, J. H., Park, S. J., Kang, H., Yang, S., Foretz, M., McBurney, M. W., Kim, M. K., Viollet, B., and Chung, J. H. (2010) AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes 59, 554-563.
20. Cohen, H. Y., Miller, C., Bitterman, K. J., Wall, N. R., Hekking, B., Kessler, B., Howitz, K. T., Gorospe, M., de Cabo, R., and Sinclair, D. A. (2004) Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305, 390-392.
21. Kaeberlein, M., McDonagh, T., Heltweg, B., Hixon, J., Westman, E. A., Caldwell, S. D., Napper, A., Curtis, R., DiStefano, P. S., Fields, S., Bedalov, A., and Kennedy, B. K. (2005) Substrate-specific activation of sirtuins by resveratrol. J. Biol. Chem. 280, 17038-17045.
22. Mukherjee, S., Lekli, I., Gurusamy, N., Bertelli, A. A., and Das, D. K. (2009) Expression of the longevity proteins by both red and white wines and their cardioprotective components, resveratrol, tyrosol, and hydroxytyrosol. Free Radic. Biol. Med. 46, 573-578.
23. Cohen, D. E., Supinski, A. M., Bonkowski, M. S., Donmez, G., and Guarente, L. P. (2009) Neuronal SIRT1 regulates endocrine and behavioral responses to calorie restriction. Genes Dev. 23, 2812-2817.
24. Alcain, F. J. and Villalba, J. M. (2009) Sirtuin inhibitors. Expert Opin. Ther. Pat. 19, 283-294.
25. Pacholec, M., Bleasdale, J. E., Chrunyk, B., Cunningham, D., Flynn, D., Garofalo, R. S., Griffith, D., Griffor, M., Loulakis, P., Pabst, B., Qiu, X., Stockman, B., Thanabal, V., Varghese, A., Ward, J., Withka, J., and Ahn, K. (2010) SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J. Biol. Chem. 285, 8340-8351.
26. Beher, D., Wu, J., Cumine, S., Kim, K. W., Lu, S. C., Atangan, L., and Wang, M. (2009) Resveratrol is not a direct activator of SIRT1 enzyme activity. Chem. Biol. Drug Des. 74, 619-624.
27. Panowski, S. H., Wolff, S., Aguilaniu, H., Durieux, J., and Dillin, A. (2007) PHA-4/Foxa mediates diet-restriction-induced longevity of C. elegans. Nature 447, 550-555.
28. Carrano, A. C., Liu, Z., Dillin, A., and Hunter, T. (2009) A conserved ubiquitination pathway determines longevity in response to diet restriction. Nature 460, 396-399.
29. Mayers, J. R., Iliff, B. W., and Swoap, S. J. (2009) Resveratrol treatment in mice does not elicit the bradycardia and hypothermia associated with calorie restriction. FASEB J. 23, 1032-1040.
30. Halls, C. and Yu, O. (2008) Potential for metabolic engineering of resveratrol biosynthesis. Trends Biotechnol. 26, 77-81.
31. Kyndt, J. A., Meyer, T. E., Cusanovich, M. A., and Van Beeumen, J. J. (2002) Characterization of a bacterial tyrosine ammonia lyase, a biosynthetic enzyme for the photoactive yellow protein. FEBS Lett. 512, 240-244.
32. Langcake, P. and Pryce, R. J. (1977) A new class of phytoalexins from grapevines. Experientia 33, 151-152.
33. Jeandet, P., Douillet-Breuil, A. C., Bessis, R., Debord, S., Sbaghi, M., and Adrian, M. (2002) Phytoalexins from the Vitaceae: biosynthesis, phytoalexin gene expression in transgenic plants, antifungal activity, and metabolism. J. Agric. Food Chem. 50, 2731-2741.
34. Hain, R., Bieseler, B., Kindl, H., Schroder, G., and Stocker, R. (1990) Expression of a stilbene synthase gene in Nicotiana tabacum results in synthesis of the phytoalexin resveratrol. Plant Mol. Biol. 15, 325-335.
35. Hain, R., Reif, H. J., Krause, E., Langebartels, R., Kindl, H., Vornam, B., Wiese, W., Schmelzer, E., Schreier, P. H., and Stocker, R. H. (1993) Disease resistance results from foreign phytoalexin expression in a novel plant. Nature 361, 153-156.
36. Stark-Lorenzen, P., Nelke, B., Hanbler, G., Muhlbach, H. P., and Thomzik, J. E. (1997) Transfer of a grapvine stilbene synthase gene to rice (Oryza sativa L.). Plant Cell Rep. 16, 668-673.
37. Szankowski, I., Briviba, K., Fleschhut, J., Schonherr, J., Jacobsen, H. J., and Kiesecker, H. (2003) Transformation of apple (Malus domestica Borkh.) with the stilbene synthase gene from grapevine (Vitis vinifera L.) and a PGIP gene from kiwi (Actinidia deliciosa). Plant Cell Rep. 22, 141-149.
38. Kobayashi, S., Ding, C. K., Nakamura, Y., Nakajima, I., and Matsumoto, R. (2000) Kiwifruits (Actinidia deliciosa) transformed with a Vitis stilbene synthase gene produce piceid (resveratrol-glucoside). Plant Cell Rep. 19, 904-910.
39. Hipskind, J. D. and Paiva, N. L. (2000) Constitutive accumulation of a resveratrol-glucoside in transgenic alfalfa increases resistance to Phoma medicaginis. Mol. Plant Microbe Interact. 13, 551-562.
40. Liu, S., Hu, Y., Wang, X., Zhong, J., and Lin, Z. (2006) High content of resveratrol in lettuce transformed with a stilbene synthase gene of Parthenocissus henryana. J. Agric. Food Chem. 54, 8082-8085.
41. Seiman, E. H. and Cresasy, L. L. (1992) Concentration of the phytoalexin resveratrol in wine. Am. J. Enol. Vitic. 43, 49-52.
42. MAgee, J. B., Smith, B. J., and Rimando, A. M. (2002) Resveratrol content of muscadine berries is affected by disease control spray program. Hortscience 37, 358-361.
43. Ralston, L., Subramanian, S., Matsuno, M., and Yu, O. (2005) Partial reconstruction of flavonoid and isoflavonoid biosynthesis in yeast using soybean type I and type II chalcone isomerases. Plant Physiol. 137, 1375-1388.
44. Watts, K. T., Lee, P. C., and Schmidt-Dannert, C. (2006) Biosynthesis of plant-specific stilbene polyketides in metabolically engineered Escherichia coli. BMC Biotechnol. 6, 22.
45. Zhang, Y., Li, S. Z., Li, J., Pan, X., Cahoon, R. E., Jaworski, J. G., Wang, X., Jez, J. M., Chen, F., and Yu, O. (2006) Using unnatural protein fusions to engineer resveratrol biosynthesis in yeast and mammalian cells. J. Am. Chem. Soc. 128, 13030-13031.
46. Trantas, E., Panopoulos, N., and Ververidis, F. (2009) Metabolic engineering of the complete pathway leading to heterologous biosynthesis of various flavonoids and stilbenoids in Saccharomyces cerevisiae. Metab. Eng. 11, 355-366.
47. Beekwilder, J., Wolswinkel, R., Jonker, H., Hall, R., de Vos, C. H., and Bovy, A. (2006) Production of resveratrol in recombinant microorganisms. Appl. Environ. Microbiol. 72, 5670-5672.
48. Katsuyama, Y., Funa, N., Miyahisa, I., and Horinouchi, S. (2007) Synthesis of unnatural flavonoids and stilbenes by exploiting the plant biosynthetic pathway in Escherichia coli. Chem. Biol. 14, 613-621.
49. Sydor, T., Schaffer, S., and Boles, E. (2010) Considerable increase in resveratrol production by recombinant industrial yeast strains with use of rich medium. Appl. Environ. Microbiol. 76, 3361-3363.
50. Smith, D. L. Jr., Nagy, T. R., and Allison, D. B. (2010) Calorie restriction: what recent results suggest for the future of ageing research. Eur. J. Clin. Invest. 40, 440-450.
51. Blagosklonny, M. V. (2007) An anti-aging drug today: from senescence-promoting genes to anti-aging pill. Drug Discov. Today 12, 218-224.
52. Milne, J. C., Lambert, P. D., Schenk, S., Carney, D. P., Smith, J. J., Gagne, D. J., Jin, L., Boss, O., Perni, R. B., Vu, C. B., Bemis, J. E., Xie, R., Disch, J. S., Ng, P. Y., Nunes, J. J., Lynch, A. V., Yang, H., Galonek, H., Israelian, K., Choy, W., Iffland, A., Lavu, S., Medvedik, O., Sinclair, D. A., Olefsky, J. M., Jirousek, M. R., Elliott, P. J., and Westphal, C. H. (2007) Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450, 712-716.
53. Smith, J. J., Kenney, R. D., Gagne, D. J., Frushour, B. P., Ladd, W., Galonek, H. L., Israelian, K., Song, J., Razvadauskaite, G., Lynch, A. V., Carney, D. P., Johnson, R. J., Lavu, S., Iffland, A., Elliott, P. J., Lambert, P. D., Elliston, K. O., Jirousek, M. R., Milne, J. C., and Boss, O. (2009) Small molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivo. BMC Syst. Biol. 3, 31.
54. Vezina, C., Kudelski, A., and Sehgal, S. N. (1975) Rapamycin (AY-22, 989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. J. Antibiot. (Tokyo) 28, 721-726.
55. Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., Pahor, M., Javors, M. A., Fernandez, E., and Miller, R. A. (2009) Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460, 392-395.
56. Spilman, P., Podlutskaya, N., Hart, M. J., Debnath, J., Gorostiza, O., Bredesen, D., Richardson, A., Strong, R., and Galvan, V. (2010) Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease. PLoS One 5, e9979.
57. Schwecke, T., Aparicio, J. F., Molnar, I., Konig, A., Khaw, L. E., Haydock, S. F., Oliynyk, M., Caffrey, P., Cortes, J., Lester, J. B., Böhm, G. A., Staunton, J., and Leadlay, P. F. (1995) The biosynthetic gene cluster for the polyketide immunosuppressant rapamycin. Proc. Natl. Acad. Sci. USA 92, 7839-7843.
58. Graziani, E. I. (2009) Recent advances in the chemistry, biosynthesis and pharmacology of rapamycin analogs. Nat. Prod. Rep. 26, 602-609.
59. Kirschning, A., Taft, F., and Knobloch, T. (2007) Total synthesis approaches to natural product derivatives based on the combination of chemical synthesis and metabolic engineering. Org. Biomol. Chem. 5, 3245-3259.
60. Weissman, K. J. (2007) Mutasynthesis-uniting chemistry and genetics for drug discovery. Trends Biotechnol. 25, 139-142.
61. Elakovich, S. D. and Stevens, K. L. (1985) Phytotoxic properties of nordihydroguaiaretic acid, a lignin from Larrea tridentata (Creosotebush). J. Chem. Ecol. 11, 27-33.
62. Lu, J. M., Nurko, J., Weakley, S. M., Jiang, J., Kougias, P., Lin, P. H., Yao, Q., and Chen, C. (2010) Molecular mechanisms and clinical applications of nordihydroguaiaretic acid (NDGA) and its derivatives: an update. Med. Sci. Monit. 16, RA93-RA100.
63. West, M., Mhatre, M., Ceballos, A., Floyd, R. A., Grammas, P., Gabbita, S. P., Hamdheydari, L., Mai, T., Mou, S., Pye, Q. N., Stewart, C., West, S., Williamson, K. S., Zemlan, F., and Hensley, K. (2004) The arachidonic acid 5-lipoxygenase inhibitor nordihydroguaiaretic acid inhibits tumor necrosis factor alpha activation of microglia and extends survival of G93A-SOD1 transgenic mice. J. Neurochem. 91, 133-143.
64. Strong, R., Miller, R. A., Astle, C. M., Floyd, R. A., Flurkey, K., Hensley, K. L., Javors, M. A., Leeuwenburgh, C., Nelson, J. F., Ongini, E., Nadon, N. L., Warner, H. R., and Harrison, D. E. (2008) Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice. Aging Cell 7, 641-650.
65. Cho, M. H., Moinuddin, S. G., Helms, G. L., Hishiyama, S., Eichinger, D., Davin, L. B., and Lewis, N. G. (2003) (+)-Larreatricin hydroxylase, an enantio-specific polyphenol oxidase from the creosote bush (Larrea tridentata). Proc. Natl. Acad. Sci. USA 100, 10641-10646.
66. Davin, L. B., Jourdes, M., Patten, A. M., Kim, K. W., Vassao, D. G., and Lewis, N. G. (2008) Dissection of lignin macromolecular configuration and assembly: comparison to related biochemical processes in allyl/propenyl phenol and lignan biosynthesis. Nat. Prod. Rep. 25, 1015-1090.
67. Vuksan, V. and Sievenpiper, J. L. (2005) Herbal remedies in the management of diabetes: lessons learned from the study of ginseng. Nutr. Metab. Cardiovasc. Dis. 15, 149-160.
68. Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., Musi, N., Hirshman, M. F., Goodyear, L. J., and Moller, D. E. (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108, 1167-1174.
69. Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S. H., Bardeesy, N., Depinho, R. A., Montminy, M., and Cantley, L. C. (2005) The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310, 1642-1646.
70. Onken, B. and Driscoll, M. (2010) Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans Healthspan via AMPK, LKB1, and SKN-1. PLoS One 5, e8758.
71. Calixto, J. B., Beirith, A., Ferreira, J., Santos, A. R., Filho, V. C., and Yunes, R. A. (2000) Naturally occurring antinociceptive substances from plants. Phytother. Res. 14, 401-418.
72. Gao, Z., Zuberi, A., Quon, M. J., Dong, Z., and Ye, J. (2003) Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumor necrosis factor-treated cells through targeting multiple serine kinases. J. Biol. Chem. 278, 24944-24950.